The Perception and Perspectives of Researchers by Indian Zones

No research evaluated the perception and perspectives of researchers from different Indian zones on India's new drugs and clinical trial rules of 2019 (NDCTR-19). The current study aimed to approach this passage. The results advance the goal of the new rules that help speed up trials and extend the pharma industry in the country. An extensive study at the national level, including all six zones, is needed to generalize researchers' beliefs on the topic.